Equities
Trinity Industries Raises Quarterly Dividend to 31 Cents
Dallas-based rail equipment maker marks 250th consecutive dividend payment, raising the quarterly payout to $0.31 per share.
Aclaris Therapeutics Details Pipeline, Cash Runway at Cantor Fitzgerald Conference
The company says cash on hand funds programs through 2028. Top-line data for its ITK inhibitor in lichen planus is due in the second half of 2027.
Roche Nominates Former Takeda Chief Weber for Board Election
Pharmaceutical giant Roche has put forward Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to its board of directors at the upcoming spring general assembly.
Royal Caribbean to acquire 50% stake in Sandals Resorts for $3B
Royal Caribbean announced plans to purchase a half‑interest in Sandals Resorts for $3 billion.
Ionis and Roche announce positive Phase 3 results for kidney drug
Ionis and Roche said their Phase 3 trial for a kidney treatment yielded positive data.
Parallel49 Equity-affiliated holders launch $PMTS secondary offering
CPI Card Group stockholders linked to Parallel49 Equity are selling up to 2.34 million shares in an underwritten secondary offering; the company receives no proceeds.
Asian equities rise driven by tech and AI demand while oil prices soften on Middle East supply reports
Asian stock markets advanced as technology and artificial‑intelligence demand boosted equities, while oil prices fell following reports on Middle East supply.
SMI leicht vorab höher, UBS-Kapitalvorschriften und Ölpreis im Fokus
Schweizer Aktienmärkte zeigen leichte Gewinne vor dem Handel, während die US-Börsen uneinheitlich schließen und Ölpreise weiter sinken.
Immunocore Reports $431M Revenue, $880M Cash as Clinical Trials Advance
Immunocore’s KIMMTRAK leads growth in oncology pipeline, with trials expanding into cutaneous and adjuvant melanoma, while cash reserves support strategic flexibility.
Immuneering Pancreatic Cancer Data Draws Cantor Healthcare Conference Attention
Shares of Immuneering (IMRX) gained focus as the company presented Phase II results for its MEK inhibitor atebimetinib showing a 104% improvement in median overall survival versus historical benchmark.
Empower India hits 5% upper circuit on acquisition of Valiance Engineers; other small‑cap stocks rally
Empower India surged to the 5% upper circuit at ₹2.48‑₹2.50 after agreeing to acquire Valiance Engineers in a cash‑free share swap. NHC Foods, Elitecon and A‑1 also posted upper‑circuit gains amid deal‑related news.
ADI Global Distribution Posts Spin Reset Amid ERP Transition and Cost-Cutting Push
The company targets $80M in annual savings by 2027, leverages tariff benefits and e-commerce growth to drive organic revenue growth of 4%–6% through 2030.
Nick Clegg’s Nscale Flotation Could Boost His Portfolio by £30m
UK ex-politician Nick Clegg’s stake in AI datacentre startup Nscale may yield a £30m windfall with its planned US IPO, despite the company’s recent losses and a $14.6bn valuation from a prior funding round.
OC Oerlikon Shares Hit Three-Year High on Growth Targets
Industrial group posts 5.5% gain as analysts upgrade outlook following capital markets day strategy update.
RBC Upgrades Zurich Insurance to Outperform, Sets CHF 650 Target
Canadian bank raises view on insurer citing Beazley acquisition and capital return plans from recent strategy update.
Amer Sports Stock Falls to 52‑Week Low of $27.31
The Finnish sporting goods maker’s shares dropped 25.8% over the past year and 25.7% year‑to‑date, even as several brokerages maintained Buy or Overweight ratings citing strong second‑quarter sales and growth prospects.
Hillman Solutions Corp shares slip to 52‑week low of $6.96 after Q2 beat
The stock’s decline comes despite a second‑quarter earnings beat and a raised full‑year outlook, with the company also announcing a $315 million acquisition to bolster its industrial segment.
First Citizens BancShares Preferred Series C Stock Falls to 52‑Week Low Near $20
The preferred shares hit a 52‑week low of $19.94, down 11.2% over the past year, while the bank reported second‑quarter adjusted net income of $691 million and a dividend yield of 7.0%.
Constellation to buy Rhode Island gas plant for $715M
Acquisition to bolster New England power portfolio, expected to boost earnings immediately.
Arch Capital Group ADR Hits 52-Week Low at $18.70
The insurer's ADR fell to its lowest level in a year, slipping nearly 15% over 12 months despite a dividend yield above 7%, as selling pressure pushes the stock into oversold territory.
No premarket stock move details provided in source
The supplied source contains only boilerplate text and lacks any substantive data on premarket movements for Netflix, Nucor, Xenon Pharmaceuticals or other equities.
Nasdaq hits record close as AI valuation and corporate developments draw attention
The Nasdaq index closed at a new record level, with focus on AI valuations and corporate developments.
Optima Health Shareholders Approve All Resolutions at AGM
Optima Health plc (AIM: OPT) secured full shareholder approval at its annual general meeting on September 22, 2026, following the March acquisition of PAM Healthcare.
Bernstein lifts Siegfried price target to CHF 140, sees potential stock double
Bernstein raised its target price for Swiss pharma contract manufacturer Siegfried to at least CHF 140 from CHF 126, keeping an Outperform rating as the company expands US API capacity.